Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'MAO-A' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 126 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Fowler, JS; Ding, YS; Logan, J; MacGregor, RR; Shea, C; Garza, V; Gimi, R; Volkow, ND; Wang, GJ; Schlyer, D; Ferrieri, R; Gatley, SJ; Alexoff, D; Carter, P; King, P; Pappas, N; Arnett, CD
      Species differences in [C-11]clorgyline binding in brain

      NUCLEAR MEDICINE AND BIOLOGY
    2. Popova, NK; Gilinsky, MA; Amstislavskaya, TG; Morosova, EA; Seif, I; De Maeyer, E
      Regional serotonin metabolism in the brain of transgenic mice lacking monoamine oxidase A

      JOURNAL OF NEUROSCIENCE RESEARCH
    3. Mourtas, S; Gatos, D; Barlos, K
      Solid phase synthesis of benzothiazolyl compounds

      TETRAHEDRON LETTERS
    4. Isin, EM; de Jonge, M; Castagnoli, N
      Studies on synthetic approaches to 1H- and 2H-indazolyl derivatives

      JOURNAL OF ORGANIC CHEMISTRY
    5. MacInnes, N; Handley, SL
      Region-dependent effects of acute and chronic tranylcypromine in vivo on [H-3]2-BFI binding to brain imidazoline I-2 sites

      EUROPEAN JOURNAL OF PHARMACOLOGY
    6. Bompart, G; Copin, N; Djouadi, F; Bastin, J; Ordener, C; Parini, A
      Monoamine oxidase in developing rat renal cortex: effect of dexamethasone treatment

      EUROPEAN JOURNAL OF PHARMACOLOGY
    7. Youdim, MBH; Gross, A; Finberg, JPM
      Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B

      BRITISH JOURNAL OF PHARMACOLOGY
    8. Trejo, F; Nekrassov, V; Sitges, M
      Characterization of vinpocetine effects on DA and DOPAC release in striatal isolated nerve endings

      BRAIN RESEARCH
    9. Mann, K; Pankok, J; Leissner, J; Benkert, O
      Effects of moclobemide on sexual performance and nocturnal erections in psychogenic erectile dysfunction

      PSYCHOPHARMACOLOGY
    10. Nicotra, A; Parvez, SH
      MPTP neurotoxins inducing cell death and a substrate for B form of enzyme monoamine oxidase

      BIOGENIC AMINES
    11. Nicotra, A; Senatori, O; Parvez, SH
      Ontogeny of monoamine oxidase A and B activities in developing chick cerebellum: a biochemical study

      BIOGENIC AMINES
    12. Popova, NK; Vishnivetskaya, GB; Ivanova, EA; Skrinskaya, JA; Seif, I
      Altered behavior and alcohol tolerance in transgenic mice lacking MAO A: acomparison with effects of MAO A inhibitor clorgyline

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    13. Bonnet, U; Leniger, T; Wiemann, M
      Moclobemide reduces intracellular pH and neuronal activity of CA3 neuronesin guinea-pig hippocampal slices - implication for its neuroprotective properties

      NEUROPHARMACOLOGY
    14. Carrasco, G; Cruz, MA; Dominguez, A; Gallardo, V; Miguel, P; Gonzalez, C
      The expression and activity of monoamine oxidase A, but not of the serotonin transporter, is decreased in human placenta from pre-eclamptic pregnancies

      LIFE SCIENCES
    15. Fowler, JS; Wang, GJ; Volkow, ND; Logan, J; Franceschi, D; Franceschi, M; MacGregor, R; Shea, C; Garza, V; Liu, N; Ding, YS
      Evidence that Ginkgo biloba extract does not inhibit MAO A and B in livinghuman brain

      LIFE SCIENCES
    16. Gnerre, C; Catto, M; Leonetti, F; Weber, P; Carrupt, PA; Altomare, C; Carotti, A; Testa, B
      Inhibition of monoamine oxidases by functionalized coumarin derivatives: Biological activities, QSARs, and 3D-QSARs

      JOURNAL OF MEDICINAL CHEMISTRY
    17. Ilani, T; Lamensdorf, I; Finberg, JPM
      Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig

      BRITISH JOURNAL OF PHARMACOLOGY
    18. Ulus, IH; Maher, TJ; Wurtman, RJ
      Characterization of phentermine and related compounds as monoamine oxidase(MAO) inhibitors

      BIOCHEMICAL PHARMACOLOGY
    19. Mukherjee, J; Yang, ZY
      Development of N-[3-(2 ',4 '-dichlorophenoxy)-2-F-18-fluoropropyl]-N-methylpropargylamine (F-18-fluoroclorgyline) as a potential PET radiotracer for monoamine oxidase-A

      NUCLEAR MEDICINE AND BIOLOGY
    20. Haffmans, PMJ; Vos, MS
      The effects of trazodone on sleep disturbances induced by brofaromine

      EUROPEAN PSYCHIATRY
    21. Langstrom, B; Kihlberg, T; Bergstrom, M; Antoni, G; Bjorkman, M; Forngren, BH; Forngren, T; Hartvig, P; Markides, K; Yngve, U; Ogren, M
      Compounds labelled with short-lived beta(+)-emitting radionuclides and some applications in life sciences. The importance of time as a parameter

      ACTA CHEMICA SCANDINAVICA
    22. Lotufo-Neto, F; Trivedi, M; Thase, ME
      Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression

      NEUROPSYCHOPHARMACOLOGY
    23. Rogde, S; Hilberg, T; Teige, B
      Fatal combined intoxication with new antidepressants. Human cases and an experimental study of postmortem moclobemide redistribution

      FORENSIC SCIENCE INTERNATIONAL
    24. Gershtein, LM; Dovedova, EL
      Regulation by delta-sleep-inducing peptide of the neurochemical changes inthe brain associated with dopaminergic system hyperactivity

      NEUROCHEMICAL RESEARCH
    25. van Haarst, AD; van Gerven, JMA; Cohen, AF; De Smet, M; Sterrett, A; Birk, KL; Fisher, AL; De Puy, ME; Goldberg, MR; Musson, DG
      The effects of moclobemide on the pharmacokinetics of the 5-HT1B/1D agonist rizatriptan in healthy volunteers

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    26. Bocchinfuso, R; Robinson, JB
      The stereoselectivity of inhibition of rat liver mitochondrial MAO-A and MAO-B by the enantiomers of 2-phenylpropylamine and their derivatives

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    27. Nicotra, A; Parvez, SH
      Methods for assaying monoamine oxidase A and B activities: recent developments.

      BIOGENIC AMINES
    28. Shih, JC; Chen, K; Ridd, MJ
      Monoamine oxidase: From genes to behavior

      ANNUAL REVIEW OF NEUROSCIENCE
    29. Cohen, C; Curet, O; Perrault, G; Sanger, DJ
      Reduction of oral ethanol self-administration in rats by monoamine oxidaseinhibitors

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    30. Pizzinat, N; Girolami, JP; Parini, A; Pecher, C; Ordener, C
      Serotonin metabolism in rat mesangial cells: Involvement of a serotonin transporter and monoamine oxidase A

      KIDNEY INTERNATIONAL
    31. Pizzinat, N; Chan, SLF; Remaury, A; Morgan, NG; Parini, A
      Characterization of monoamine oxidase isoforms in human islets of Langerhans

      LIFE SCIENCES
    32. Ordway, GA; Farley, JT; Dilley, GE; Overholser, JC; Meltzer, HY; Balraj, EK; Stockmeier, CA; Klimek, V
      Quantitative distribution of monoamine oxidase A in brainstem monoamine nuclei is normal in major depression

      BRAIN RESEARCH
    33. Shih, JC; Thompson, RF
      Monoamine oxidase in neuropsychiatry and behavior

      AMERICAN JOURNAL OF HUMAN GENETICS
    34. JEGHAM S; GEORGE P
      MONOAMINE-OXIDASE A AND B INHIBITORS

      Expert opinion on therapeutic patents
    35. WOUTERS J
      STRUCTURAL ASPECTS OF MONOAMINE-OXIDASE AND ITS REVERSIBLE INHIBITION

      Current medicinal chemistry
    36. WOUTERS J; BAUDOUX G
      FIRST PARTIAL 3-DIMENSIONAL MODEL OF HUMAN MONOAMINE-OXIDASE-A

      Proteins
    37. LAKSHMANA MK; RAO BSS; DHINGRA NK; RAVIKUMAR R; GOVINDAIAH; SUDHA S; METI BL; RAJU TR
      ROLE OF MONOAMINE-OXIDASE TYPE-A AND TYPE-B ON THE DOPAMINE METABOLISM IN DISCRETE REGIONS OF THE PRIMATE BRAIN

      Neurochemical research
    38. STERNIC N; KACAR A; FILIPOVIC S; SVETEL M; KOSTIC VS
      THE THERAPEUTIC EFFECT OF MOCLOBEMIDE, A REVERSIBLE SELECTIVE MONOAMINE-OXIDASE A INHIBITOR, IN PARKINSONS-DISEASE

      Clinical neuropharmacology
    39. GERARDY J; DRESSE A
      REGIONAL ACTION OF BROFAROMINE ON RAT-BRAIN MAO-A AND MAO-B

      Progress in neuro-psychopharmacology & biological psychiatry
    40. Rosenzweig, P; Patat, A; Curet, O; Durrieu, G; Dubruc, C; Zieleniuk, I; Legangneux, E
      Clinical pharmacology of befloxatone: a brief review

      JOURNAL OF AFFECTIVE DISORDERS
    41. FERIGOLO M; BARROS HMT; MARQUARDT AR; TANNHAUSER M
      COMPARISON OF BEHAVIORAL-EFFECTS OF MOCLOBEMIDE AND DEPRENYL DURING FORCED SWIMMING

      Pharmacology, biochemistry and behavior
    42. HOLSCHNEIDER DP; KUMAZAWA T; CHEN K; SHIH JC
      TISSUE-SPECIFIC EFFECTS OF ESTROGEN ON MONOAMINE-OXIDASE-A AND MONOAMINE-OXIDASE-B IN THE RAT

      Life sciences (1973)
    43. ALTOMARE C; CELLAMARE S; SUMMO L; CATTO M; CAROTTI A; THULL U; CARRUPT PA; TESTA B; STOECKLIEVANS H
      INHIBITION OF MONOAMINE OXIDASE-B BY CONDENSED PYRIDAZINES AND PYRIMIDINES - EFFECTS OF LIPOPHILICITY AND STRUCTURE-ACTIVITY-RELATIONSHIPS

      Journal of medicinal chemistry
    44. HADDJERI N; DEMONTIGNY C; CURET O; BLIER P
      EFFECT OF THE REVERSIBLE MONOAMINE OXIDASE-A INHIBITOR BEFLOXATONE ONTHE RAT 5-HYDROXYTRYPTAMINE NEUROTRANSMISSION

      European journal of pharmacology
    45. ROSENZWEIG P; PATAT A; ZIELENIUK I; CIMAROSTI I; ALLAIN H; GANDON JM
      COGNITIVE PERFORMANCE IN ELDERLY SUBJECTS AFTER A SINGLE-DOSE OF BEFLOXATONE, A NEW REVERSIBLE SELECTIVE MONOAMINE-OXIDASE-A INHIBITOR

      Clinical pharmacology and therapeutics
    46. LAKSHMANA MK; RAO BSS; DHINGRA NK; RAVIKUMAR R; GOVINDAIAH; RAMACHANDRA; METI BL; RAJU TR
      CHRONIC (-) DEPRENYL ADMINISTRATION INCREASES DENDRITIC ARBORIZATION IN CA3 NEURONS OF HIPPOCAMPUS AND ACHE ACTIVITY IN SPECIFIC REGIONS OFTHE PRIMATE BRAIN

      Brain research
    47. BERGSTROM M; WESTERBERG G; KIHLBERG T; LANGSTROM B
      SYNTHESIS OF SOME C-11 LABELED MAO-A INHIBITORS AND THEIR IN-VIVO UPTAKE KINETICS IN RHESUS-MONKEY BRAIN

      Nuclear medicine and biology
    48. BERGSTROM M; WESTERBERG G; LANGSTROM B
      C-11 HARMINE AS A TRACER FOR MONOAMINE-OXIDASE-A (MAO-A) - IN-VITRO AND IN-VIVO STUDIES

      Nuclear medicine and biology
    49. KATO M; IWATA H; KATAYAMA T; ASAI H; NARITA H; ENDO T
      POSSIBLE THERAPEUTIC EFFECT OF T-794, A NOVEL REVERSIBLE INHIBITOR OFMONOAMINE OXIDASE-A, ON POSTSTROKE EMOTIONAL DISTURBANCES, ASSESSED IN ANIMAL-MODELS OF DEPRESSION

      Biological & pharmaceutical bulletin
    50. PATAT A; DUBRUC C; DESCHAMP C; DURRIEU G; TROCHERIE S; CIMAROSTI I; ALLAIN H; ROSENZWEIG P; GANDON JM
      EEG, MAO-A INHIBITION, PHARMACOKINETICS AND SAFETY OF BEFLOXATONE IN THE ELDERLY

      Human psychopharmacology
    51. SCHALLREUTER KU; PITTELKOW MR; SWANSON NN; BEAZLEY WD; KORNER C; EHRKE C; BUTTNER G
      ALTERED CATECHOLAMINE SYNTHESIS AND DEGRADATION IN THE EPIDERMIS OF PATIENTS WITH ATOPIC ECZEMA

      Archives of dermatological research
    52. JURUENA MF; PIRES MLN; CALIL HM
      MOCLOBEMIDE EFFECTS ON PROLACTIN PLASMA-LEVELS IN HEALTHY-INDIVIDUALS- THE HORMONAL INCREASE INDUCED BY A SINGLE-DOSE IS MAINTAINED DURINGA 4-WEEK PERIOD OF DRUG INTAKE

      International clinical psychopharmacology
    53. SAURA J; ANDRES N; ANDRADE C; OJUEL J; ERIKSSON K; MAHY N
      BIPHASIC AND REGION-SPECIFIC MAO-B RESPONSE TO AGING IN NORMAL HUMAN BRAIN

      Neurobiology of aging
    54. BERGSTROM M; WESTERBERG G; NEMETH G; TRAUT M; GROSS G; GREGER G; MULLERPELTZER H; SAFER A; ECKERNAS SA; GRAHNER A; LANGSTROM B
      MAO-A INHIBITION IN BRAIN AFTER DOSING WITH ESUPRONE, MOCLOBEMIDE ANDPLACEBO IN HEALTHY-VOLUNTEERS - IN-VIVO STUDIES WITH POSITRON EMISSION TOMOGRAPHY

      European Journal of Clinical Pharmacology
    55. ZHU QS; SHIH JC
      AN EXTENSIVE REPEAT STRUCTURE DOWN-REGULATES HUMAN MONOAMINE-OXIDASE-A PROMOTER ACTIVITY INDEPENDENT OF AN INITIATOR-LIKE SEQUENCE

      Journal of neurochemistry
    56. MOUSSEAU DD; BAKER GB; BUTTERWORTH RF
      INCREASED DENSITY OF CATALYTIC SITES AND EXPRESSION OF BRAIN MONOAMINE-OXIDASE-A IN HUMANS WITH HEPATIC-ENCEPHALOPATHY

      Journal of neurochemistry
    57. PALMER SL; MABIC S; CASTAGNOLI N
      PROBING THE ACTIVE-SITES OF MONOAMINE-OXIDASE-A AND MONOAMINE-OXIDASE-B WITH 1,4-DISUBSTITUTED TETRAHYDROPYRIDINE SUBSTRATES AND INACTIVATORS

      Journal of medicinal chemistry
    58. OZAITA A; OLMOS G; BORONAT MA; LIZCANO JM; UNZETA M; GARCIASEVILLA JA
      INHIBITION OF MONOAMINE-OXIDASE-A AND MONOAMINE-OXIDASE-B ACTIVITIES BY IMIDAZOL(INE) GUANIDINE DRUGS, NATURE OF THE INTERACTION AND DISTINCTION FROM I-2-IMIDAZOLINE RECEPTORS IN RAT-LIVER/

      British Journal of Pharmacology
    59. KIM H; SABLIN SO; RAMSAY RR
      INHIBITION OF MONOAMINE-OXIDASE-A BY BETA-CARBOLINE DERIVATIVES

      Archives of biochemistry and biophysics
    60. HARTTER S; DINGEMANSE J; BAIER D; ZIEGLER G; HIEMKE C
      THE ROLE OF CYTOCHROME-P450 2D6 IN THE METABOLISM OF MOCLOBEMIDE

      European neuropsychopharmacology
    61. LAKSHMANA MK; JAGADEESH S; SUBHASH MN
      INCREASED ACETYLCHOLINESTERASE ACTIVITY IN SELECTED REGIONS OF RAT-BRAIN AFTER CHRONIC (-)-DEPRENYL ADMINISTRATION

      Neurochemical research
    62. SAURA J; BLEUEL Z; ULRICH J; MENDELOWITSCH A; CHEN K; SHIH JC; MALHERBE P; DAPRADA M; RICHARDS JG
      MOLECULAR NEUROANATOMY OF HUMAN MONOAMINE OXIDASE-A AND OXIDASE-B REVEALED BY QUANTITATIVE ENZYME AUTORADIOGRAPHY AND IN-SITU HYBRIDIZATIONHISTOCHEMISTRY

      Neuroscience
    63. EGASHIRA T; TAKAYAMA F; YAMANAKA Y
      EFFECTS OF LONG-TERM TREATMENT WITH DICYCLIC, TRICYCLIC, TETRACYCLIC,AND NONCYCLIC ANTIDEPRESSANT DRUGS ON MONOAMINE-OXIDASE ACTIVITY IN MOUSE-BRAIN

      General pharmacology
    64. REIMANN IW; JOBERT M; GLEITER CH; TURRI M; BIECK PR; HERRMANN WM
      DIFFERENT MODES OF DATA-PROCESSING AND STATISTICAL TESTING APPLIED TOTHE SAME SET OF PHARMACO-EEG RECORDINGS - EFFECTS ON THE EVALUATION OF A SELECTIVE AND THE REVERSIBLE MAO-A-INHIBITOR (BROFAROMINE)

      Neuropsychobiology
    65. VOLZ HP; GLEITER CH; WALDMEIER PC; STRUCK M; MOLLER HJ
      BROFAROMINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE

      Journal of neural transmission
    66. BERGSTROM M; LU L; ERIKSSON B; MARQUES M; BJURLING P; ANDERSSON Y; LANGSTROM B
      MODULATION OF ORGAN UPTAKE OF C-11 LABELED 5-HYDROXYTRYPTOPHAN

      Biogenic amines
    67. GUELMAN LR; ZIEHER LM; ZUBILETE MAZ; DOPICO AM
      ACTIVITIES OF MONOAMINE OXIDASE-A AND OXIDASE-B IN ADULT-RAT CEREBELLUM FOLLOWING NEONATAL X-IRRADIATION

      Neuroscience research
    68. BRYANLLUKA LJ; SEERS H; SHARPE I
      AMEZINIUM AND DEBRISOQUINE ARE SUBSTRATES OF UPTAKE, AND POTENT INHIBITORS OF MONOAMINE-OXIDASE IN PERFUSED LUNGS OF RATS

      Naunyn-Schmiedeberg's archives of pharmacology
    69. DARMANI NA
      DIFFERENTIAL POTENTIATION OF L-TRYPTOPHAN-INDUCED HEAD-TWITCH RESPONSE IN MICE BY COCAINE AND SERTRALINE

      Life sciences
    70. CURET O; DAMOISEAU G; AUBIN N; SONTAG N; ROVEI V; JARREAU FX
      BEFLOXATONE, A NEW REVERSIBLE AND SELECTIVE MONOAMINE OXIDASE-A INHIBITOR .1. BIOCHEMICAL PROFILE

      The Journal of pharmacology and experimental therapeutics
    71. CESURA AM; GOTTOWIK J; LAHM HW; LANG G; IMHOF R; MALHERBE P; ROTHLISBERGER U; DAPRADA M
      INVESTIGATION ON THE STRUCTURE OF THE ACTIVE-SITE OF MONOAMINE OXIDASE-B BY AFFINITY LABELING WITH THE SELECTIVE INHIBITOR LAZABEMIDE AND BY SITE-DIRECTED MUTAGENESIS

      European journal of biochemistry
    72. BURKE WJ; SCHMITT CA; GILLESPIE KN; LI SW
      NOREPINEPHRINE TRANSMITTER METABOLITE IS A SELECTIVE CELL-DEATH MESSENGER IN DIFFERENTIATED RAT PHEOCHROMOCYTOMA CELLS

      Brain research
    73. CARLO P; VIOLANI E; DELRIO M; OLASMAA M; SANTAGATI S; MAGGI A; PICOTTI GB
      MONOAMINE-OXIDASE-B EXPRESSION IS SELECTIVELY REGULATED BY DEXAMETHASONE IN CULTURED RAT ASTROCYTES

      Brain research
    74. LAUX G; VOLZ HP; MOLLER HJ
      NEWER AND OLDER MONOAMINE-OXIDASE INHIBITORS - A COMPARATIVE PROFILE

      CNS DRUGS
    75. VOLZ HP; GLEITER CH; STRUCK M; MOLLER HJ
      BROFAROMINE - INSIGHT INTO THE NATURE OF DRUG DEVELOPMENT

      CNS DRUGS
    76. COMMISSARIS RL; HUMRICH J; JOHNS J; GEERE DG; FONTANA DJ
      THE EFFECTS OF SELECTIVE AND NONSELECTIVE MONOAMINE-OXIDASE (MAO) INHIBITORS ON CONFLICT BEHAVIOR IN THE RAT

      Behavioural pharmacology
    77. MIGUEZ JM; SIMONNEAUX V; PEVET P
      EVIDENCE FOR A REGULATORY ROLE OF MELATONIN ON SEROTONIN RELEASE AND UPTAKE IN THE PINEAL-GLAND

      Journal of neuroendocrinology
    78. DENBOER JA; VANVLIET IM; WESTENBERG HGM
      RECENT DEVELOPMENTS IN THE PSYCHOPHARMACOLOGY OF SOCIAL PHOBIA

      European archives of psychiatry and clinical neuroscience
    79. PATAT A; GANDON JM; DURRIEU G; LECOZ F; CURET O; CIMAROSTI I; ALLAIN H
      EFFECTS OF SINGLE AND MULTIPLE DOSES OF A NEW REVERSIBLE MAO-A INHIBITOR, BEFLOXATONE, ON PSYCHOMOTOR PERFORMANCE AND MEMORY IN HEALTHY-SUBJECTS

      Human psychopharmacology
    80. BRANNAN T; PRIKHOJAN A; MARTINEZTICA J; YAHR MD
      IN-VIVO COMPARISON OF THE EFFECTS OF INHIBITION OF MAO-A VERSUS MAO-BON STRIATAL L-DOPA AND DOPAMINE METABOLISM

      Journal of neural transmission
    81. MOUREAU F; WOUTERS J; DEPAS M; VERCAUTEREN DP; DURANT F; DUCREY F; KOENIG JJ; JARREAU FX
      A REVERSIBLE MONOAMINE-OXIDASE INHIBITOR TOLOXATONE - COMPARISON OF ITS PHYSICOCHEMICAL PROPERTIES WITH THOSE OF OTHER INHIBITORS INCLUDINGBROFAROMINE, HARMINE, R40519 AND MOCLOBEMIDE

      European journal of medicinal chemistry
    82. VOITENKO NN; KOLPAKOV VG; POPOVA NK; ALEKHINA TA
      PREDISPOSITION TO CATATONIC REACTIONS, MONOAMINE-OXIDASE AND DELTA-SLEEP-INDUCING PEPTIDE IN RATS

      Biogenic amines
    83. DELINISTULA A; MIKKELSEN H; ANGST J
      THERAPEUTIC EFFICACY OF ANTIDEPRESSANTS IN AGITATED ANXIOUS DEPRESSION - A METAANALYSIS OF MOCLOBEMIDE STUDIES

      Journal of affective disorders
    84. BEL N; ARTIGAS F
      IN-VIVO EVIDENCE FOR THE REVERSIBLE ACTION OF THE MONOAMINE-OXIDASE INHIBITOR BROFAROMINE ON 5-HYDROXYTRYPTAMINE RELEASE IN RAT-BRAIN

      Naunyn-Schmiedeberg's archives of pharmacology
    85. LUQUE JM; KWAN SW; ABELL CW; DAPRADA M; RICHARDS JG
      CELLULAR EXPRESSION OF MESSENGER-RNAS ENCODING MONOAMINE-OXIDASE-A AND MONOAMINE-OXIDASE-B IN THE RAT CENTRAL-NERVOUS-SYSTEM

      Journal of comparative neurology
    86. YOSHIMI K; IWATA N
      A SUPPLEMENTAL MEASURE OF STAY-TIMES IN THE LIGHT BOX ON STEP-THROUGHPASSIVE-AVOIDANCE

      Japanese Journal of Pharmacology
    87. KHVATOVA EM; RUBANOVA NA; PRUDCHENKO IA; MIKHALEVA II
      EFFECTS OF DELTA-SLEEP-INDUCING PEPTIDE (DSIP) AND SOME ANALOGS ON THE ACTIVITY OF MONOAMINE-OXIDASE TYPE-A IN RAT-BRAIN UNDER HYPOXIA STRESS

      FEBS letters
    88. THULL U; KNEUBUHLER S; GAILLARD P; CARRUPT PA; TESTA B; ALTOMARE C; CAROTTI A; JENNER P; MCNAUGHT KSP
      INHIBITION OF MONOAMINE-OXIDASE BY ISOQUINOLINE DERIVATIVES - QUALITATIVE AND 3D-QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS

      Biochemical pharmacology
    89. NAIR NPV; AHMED SK; KIN NMKNY; WEST TEG
      REVERSIBLE AND SELECTIVE INHIBITORS OF MONOAMINE-OXIDASE-A IN THE TREATMENT OF DEPRESSED ELDERLY PATIENTS

      Acta psychiatrica Scandinavica
    90. DAVIS BA; KENNEDY SH; DSOUZA J; DURDEN DA; GOLDBLOOM DS; BOULTON AA
      CORRELATIONS OF PLASMA AND URINARY PHENYLACETIC ACID AND PHENYLETHYLAMINE CONCENTRATIONS WITH EATING BEHAVIOR AND MOOD RATING SCORES IN BROFAROMINE-TREATED WOMEN WITH BULIMIA-NERVOSA

      Journal of psychiatry & neuroscience
    91. ALVAREZ EF; MARCO JL; GARCIA CF; PEREZ V; UNZETA M
      SYNTHESIS OF SOME 2-[(5-METHOXY-1-METHYL)INDOL-2-YL]ETHYLAMINES AS SELECTIVE INHIBITORS OF MONOAMINE OXIDASE-A AND OXIDASE-B

      Anales de quimica
    92. BRANNAN T; PRIKHOJAN A; YAHR MD
      EFFECT OF A SELECTIVE MAO-A INHIBITOR (RO-41-1049) ON STRIATAL L-DOPAAND DOPAMINE METABOLISM - AN IN-VIVO STUDY

      Journal of neural transmission. Parkinson's disease and dementia section
    93. KABUTO H; YOKOI I; ENDO A; TAKEI M; KURIMOTO T; MORI A
      CHRONIC ADMINISTRATION OF CITALOPRAM INHIBITED EL MOUSE CONVULSIONS AND DECREASED MONOAMINE OXIDASE-A ACTIVITY

      Acta medica Okayama
    94. RAMAEKERS JG; VANVEGGEL LMA; OHANLON JF
      A CROSS-STUDY COMPARISON OF THE EFFECTS OF MOCLOBEMIDE AND BROFAROMINE ON ACTUAL DRIVING PERFORMANCE AND ESTIMATED SLEEP

      Clinical neuropharmacology
    95. UNZETA M; BARON S; PEREZ V; AMBROSIO S; MAHY N
      SEX-RELATED EFFECTS OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDRO-PYRIDINE TREATMENT MAY BE RELATED TO DIFFERENCES IN MONOAMINE-OXIDASE-B

      Neuroscience letters
    96. RAO VLR; QURESHI IA; BUTTERWORTH RF
      ACTIVITIES OF MONOAMINE OXIDASE-A AND OXIDASE-B ARE ALTERED IN THE BRAINS OF CONGENITALLY HYPERAMMONEMIC SPARSE-FUR (SPF) MICE

      Neuroscience letters
    97. DENBOER JA; VANVLIET IM; WESTENBERG HGM
      RECENT ADVANCES IN THE PSYCHOPHARMACOLOGY OF SOCIAL PHOBIA

      Progress in neuro-psychopharmacology & biological psychiatry
    98. GERARDY J
      EFFECT OF MOCLOBEMIDE ON RAT-BRAIN MONOAMINE OXIDASE-A AND OXIDASE-B - COMPARISON WITH HARMALINE AND CLORGYLINE

      Progress in neuro-psychopharmacology & biological psychiatry
    99. VERHOEVEN WMA
      BROFAROMINE IN ENDOGENOUS-DEPRESSION

      Progress in neuro-psychopharmacology & biological psychiatry
    100. VOLZ HP; FALTUS F; MAGYAR I; MOLLER HJ
      BROFAROMINE IN TREATMENT-RESISTANT DEPRESSED-PATIENTS - A COMPARATIVETRIAL VERSUS TRANYLCYPROMINE

      Journal of affective disorders


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 14/08/20 alle ore 09:49:22